Strategic Training to Optimize Neurocognitive Functions in Older Adults
NCT ID: NCT03988829
Last Updated: 2022-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2018-09-30
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Engagement and Aging Mind
NCT05924490
Training to Enhance Cognition in Older Adults
NCT03900702
Mindfulness and Attention Training Intervention to Lower Distractibility in Aging
NCT05974605
Effects of Exercise and Cognitive Training on Cognitive Function in Older Adults
NCT01038726
A Comparison of Two Approaches to Developing Brain Health Programs
NCT04822129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The current proposal has three training arms and utilizes game-based simulations in all arms in healthy older adults. The first two arms use experimenter-designed simulation games, where participants will be trained on either predictable low attentional control (Arm 1) or unpredictable high attentional control (Arm 2) working memory games. The third arm uses a commercially available strategy game requiring the highest level of attentional control, by adding multi-tasking to the unpredictable attentional shifts in working memory. In all three training arms, neural and cognitive changes in near (secondary outcome) and far (primary outcome) transfer tasks will be examined immediately after the intervention; cognitive changes will also be assessed at 6-month post-training duration. Additionally, a single-session, baseline neuroimaging data (no training) will be collected in a functional control group of younger adults. We expect that the high attentional control training arms will greatly improve both near and far cognition in older adults, with cognitive frailty interacting with the extent to which attentional control is trained. High attentional control training arms are also expected to heighten compensatory brain activation after the intervention, for both near and far in-scanner transfer tasks, mimicking the baseline activity of younger brains. These training arms are also expected to positively impact brain structures that progressively decline with aging. This clinical trial will result in the development of behavioral intervention tools, which will have the potential to delay the onset of memory-related disorders, such as AD, by instantiating durable improvements in cognitive functions in older adults. Such interventions can not only improve an individual's quality of life but also decrease the financial burden of a rapidly aging society.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Additionally, a single-session functional neuroimaging dataset will be collected in a functional control group of younger adults; they will not undergo any intervention.
PREVENTION
TRIPLE
No masking is required for the younger adults, as they will not be undergoing any training.
The PI will be blinded to training assignment of any subject, and will only analyze de-identified data.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low-C
In an experimenter-designed simulation game, participants will be trained on predictable low attentional control shifts during working memory.
Low-C
This is the active control group, where participants will be trained to play an experimenter developed game that requires least attentional control among all arms.
High-C
In an experimenter-designed simulation game, participants will be trained on unpredictable high attentional control shifts during working memory.
High-C
In this intervention, participants will be trained on this experimenter developed game which requires a lot of attentional control.
High-C+
In this commercially-available video game, in addition to unpredictable shifts of attentional control in working memory, task switching and resource planning will be trained.
High-C+
A commercial video game will be used that requires a lot of demand on attentional control.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low-C
This is the active control group, where participants will be trained to play an experimenter developed game that requires least attentional control among all arms.
High-C
In this intervention, participants will be trained on this experimenter developed game which requires a lot of attentional control.
High-C+
A commercial video game will be used that requires a lot of demand on attentional control.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Learned English before age 5
* If female, not pregnant or likely to be pregnant
* Right-handed
* Mini Mental State (MMSE) score of 26 or greater (for older adults only), Montreal Cognitive Assessment (MoCA) score of 24 or more (for older adults only)
* The physical and sensory capacity sufficient to undertake a functional magnetic resonance imaging study
Exclusion Criteria
* Visual acuity of less than 20/30 on the Snellen eye chart after correction
* Diagnosis of any major psychiatric or neurologic disorders
* History of cardiovascular disease other than treated hypertension
* Illness or trauma affecting the central nervous system
* Substance/alcohol abuse, and medication with anti-depressants, anti-psychotics, or hypnotics other than occasionally at bedtime
* Structural magnetic resonance imaging reveal evidence of pathology (e.g. infarction)
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Texas Southwestern Medical Center
OTHER
National Institute on Aging (NIA)
NIH
The University of Texas at Dallas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chandramallika Basak, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas at Dallas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Center for Vital Longevity (UT Dallas)
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form: Older adults
Document Type: Informed Consent Form: Younger adults
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB 20-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.